Study of the efficiency of a peptide-based cosmetic product in topical therapy for diffuse alopecia

Abstract

Background: Hair loss is a significant health problem; hence, individuals experiencing hair loss immediately visit a doctor for treatment. Diffuse (symptomatic) alopecia can be the result of various external and internal factors. A doctor should determine the cause of the hair loss and prescribe treatment, including topical agents.

Aim: to study the clinical efficacy of hair spray with peptides in the treatment of patients with diffuse alopecia and its effect on the trichogramma parameters.

Materials and methods: Thirty female patients with diffuse alopecia, aged from 18 to 59 years, were monitored in the Center of Medical Cosmetology of the I.I. Mechnikov North-Western State Medical University. In a controlled comparative study, the patients were divided into two equal groups. In group 1 (main), the drug of choice was a spray based on peptides; while in group 2 (comparison), a cosmetic product based on enzymes was applied. The drugs were used topically for 3 months. Patients were examined using questionnaires (objective assessment by the doctor and subjective evaluation by the patient) and photographs and by assessing the morphometric parameters of hair growth before treatment, 3 months after the start of treatment, and 1 month after treatment termination.

Results: In group 1, in the parietal zone, the hair density increased significantly by 19% after 3 months and by 23% after 4 months. The number of anagen hair increased by 8% after 3 months and by 16% after 4 months, with a corresponding decrease in the number of telogen hair compared to the initial level. In the occipital zone, the number of anagen hair increased by 7% after 3 months and by 13% after 4 months, with the corresponding dynamics of telogen hair compared to the initial level. The cosmetic product has been shown to be tolerated well, and no allergic reactions were noted.

Conclusion: The peptide-based spray can be recommended for patients with diffuse alopecia as a topical therapy.

Keywords

diffuse alopecia / peptides / topical therapy

References

[1] Batkaeva EA, Gallyamova YuA, Khassan Al’-khadzh Khaled. Diffuse alopecia: Methodical Manual. Moscow: Russian Medical Academy of Postgraduate Education; 2010. (in Russian)

[2] Баткаева Э.А., Галлямова Ю.А., Хассан Аль-хадж Халед. Диффузная алопеция: Методическое пособие. М.: РМАПО; 2010.

[3] Zlotogorsky A, Shapiro J. Trichology. Transl. from Engl. Kiev: Rodovshch; 2016. (in Russian)

[4] Злотогорский А., Шапиро Д. Трихология. Пер. с англ. Киев: Родовщ; 2016.

[5] Dribnokhod YuYu. Hair treatment in cosmetology. St. Petersburg: SpetsLit; 2015. (in Russian)

[6] Дрибноход Ю.Ю. Лечение волос в косметологии. СПб.: СпецЛит; 2015.

[7] Adaskevich VP, Myadelets OD, Tikhonovskaya IV. Alopecia. Moscow: Medical book; 2000. (in Russian)

[8] Адаскевич В.П., Мяделец О.Д., Тихоновская И.В. Алопеция. М.: Медицинская книга; 2000.

[9] Uryupina EL, Malishevskaya NP. The condition of the psychoemotional status in patients with diffuse telogen hair loss. Russian Journal of Skin and Venereal Diseases. 2017;20(5):285-9. (in Russian)

[10] Урюпина Е.Л., Малишевская Н.П. Психоэмоциональный статус у больных диффузным телогенным выпадением волос // Российский журнал кожных и венерических болезней. 2017;20(5): 285-9.

[11] Simbirtsev AS. Prospects for the use of preparations of cytokines in dermatovenereology. Practical Medicine. Russian Journal. 2011;49(2):15-2. (in Russian)

[12] Симбирцев А.С. Перспективы применения препаратов цитокинов в дерматовенерологии // Практическая медицина. 2011;49(2): 15-22.

RIGHTS & PERMISSIONS

Eco-Vector